QuTEM AB has expanded its reach in the United States by partnering with the Multiscale Microscopy Core (MMC) at Oregon Health & Science University (OHSU) to open a new laboratory in Portland, Oregon. This facility marks QuTEM’s second U.S. satellite laboratory, following its Boston site, enhancing the company’s capabilities to serve the cell and gene therapy sector on the West Coast with specialized transmission electron microscopy (TEM) services.
Located in Portland, the new laboratory is designed to support advanced therapy and nanomedicine developers with GMP-certified TEM services and nanoparticle quality control analysis. This expansion is intended to facilitate easier sample handling and reduce logistical challenges for biotechnology companies in Seattle, the San Francisco Bay Area, and San Diego. By providing a domestic option for sample processing, QuTEM aims to mitigate risks associated with temperature changes, handling, and customs delays typically encountered with international shipping.
The Portland facility operates a Biosafety Level 2 (BSL-2) laboratory capable of processing a variety of samples, including Adeno-Associated Virus (AAV), lentiviral vectors, lipid nanoparticles (LNPs), and other nanoparticle-based products. OHSU’s microscopy scientists prepare and image samples using QuTEM’s established protocols. These images are then analyzed at QuTEM’s Stockholm headquarters using their proprietary software, Gridsee, which assesses Critical Quality Attributes (CQAs) such as particle morphology and size distribution.
Josefina Nilsson, CEO of QuTEM AB, stated that the new laboratory responds to the demands of regional clients who sought access to QuTEM’s satellite laboratory model, first implemented in Boston. This strategic move, she emphasized, aims to deliver high-quality analytical services without compromising development speed.
The collaboration functions under OHSU’s core service model, with QuTEM utilizing MMC’s equipment and expertise on a fee-for-service basis. QuTEM maintains responsibility for image analysis and quality assurance, ensuring consistency across its facilities through standardized protocols and software. The Portland lab is now ready to accept new U.S. projects, offering research and development analysis and support for programs progressing toward GMP release testing.
About QuTEM
QuTEM AB is a Stockholm-based provider of GMP-certified TEM services and quality control analysis of nanoparticles. It serves biopharmaceutical companies developing AAV, LNP and other viral vector-based therapies. The QuTEM team builds on almost twenty years of hands-on electron microscopy experience. It combines latest-generation instruments with Gridsee, its in-house image analysis software, and validated methods to deliver objective, reproducible data from early research through GMP release. With satellite laboratories in Boston and Portland, QuTEM supports developers in Europe and across the United States.
About the OHSU Multiscale Microscopy Core
The Multiscale Microscopy Core (MMC) at Oregon Health & Science University provides academic and commercial users with access to advanced electron microscopy platforms, together with project consultation, specimen preparation, imaging and analysis services. The core was established in 2013 and is housed in the OHSU’s Robertson Life Sciences Building in Portland, Oregon. Its instruments include a Glacios cryo-transmission electron microscope, a Talos 120C G2 transmission electron microscope, a Helios UC5 Focused Ion Beam scanning electron microscope (FIB-SEM) with cryo capabilities, a Helios G3 FIB-SEM and an Apreo Volume Scope Serial Block face SEM. The MMC is a member of the OHSU University Shared Resource Cores.
Jingyi Zhang
QUTEM AB
Legal Disclaimer:
The information contained in this article has been provided by independent third-party contributors, clients, or content partners. We do not independently verify the accuracy, completeness, legality, ownership, licensing, or reliability of submitted content, including text, images, videos, trademarks, or other media materials. The submitting party is solely responsible for ensuring that all content, including images and media assets, complies with applicable copyright, trademark, licensing, and intellectual property laws. We disclaim liability for any unauthorized use of copyrighted or proprietary materials by third parties. If you believe that any content published on this platform infringes your intellectual property rights, kindly contact the author above for prompt review and resolution.